Kaitlin Seymour Roberson


Kaitlin is Co-founder & CEO of Cacti Therapeutics, a biotech company developing FDA-approved psychedelic-derived therapies for chronic pain, inflammation, and headache disorders. Kaitlin received her Master’s degree in Human Development and Psychology from Harvard University and has professional experience in trauma care and business finance. Her passion is helping people experience growth and transformation through the adversity of spiritual, sexual or attachment traumas.



Mental Health & WellnessHealthcarePharmaceuticals & MedicineBiotechnology
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.